New Developments in Women’s Cancer

07-26-2017 8:53 AM

2017 Foundation Cancer Grants Announced!

This year, the Foundation awarded 12 highly-competitive grants totaling $1.2 million to some of the most respected institutions in the country. 

The 2017 slate of grants includes a wide range of critical research areas. Washington University medical scientists are investigating treatment for chemo-resistant ovarian cancer. At the University of Arizona, innovative research is underway for endometrial cancer patients. 

The Mary Kay Foundation℠ Scientific Review Committee reviewed 80 applicants before selecting 12 of the best to receive grants of $100,000 each. For more information, you can read the entire press release in the Mary Kay Press Room.

Breast Cancer Treatment Can Affect Future Pregnancies.

Women diagnosed with breast cancer before age 39 — who still want to have children — should talk to their doctors about fertility options before undergoing treatment.

 A new study found that treatment can affect your ability to conceive. However, the study found that treatment had no significant impact on stillbirths or miscarriages. Medscape recently published this news on July 11, 2017 in the article: Odds of Pregnancy Reduced for One Third of Cancer Survivors.

Can some cancer survivors skip chemo?

Yes, according to new recommendations by the American Society of Clinical Oncology. Doctors can use the Agendia’s MammaPrint® test to determine the biology of tumors to determine which ones are more likely to spread.

Any woman in the early stages of breast cancer should ask about MammaPrint® and Agendia’s other breast cancer tests. These tests can even be run on a sample of past tissue from biopsies or surgeries if the tissue was embedded in paraffin.

Doctor hasn’t heard of this? No problem. Call 888-321-2732 for an Agendia oncology specialist to help you.

New Test to Detect Ovarian Cancer.

A British company founds its blood test could be a breakthrough in helping women with ovarian cancer have better outcomes in surgery. The current tests available have not shown effective. The study helps determine if ovarian tumors are cancerous or benign.

The next step? For the test to meet European and US requirements. Reported in the July 4, 2017 Medscape article, Blood Test Detects Ovarian Cancer in Study.

If you like The Wednesday Report, be sure to share it!

Stacy Graves is a contributing editor of The Mary Kay Foundation℠ blog and website. She’s worked in some type of communication role for Mary Kay since 1994 — loving every minute. She’s passionate about everything Mary Kay. You can connect with her by her website or LinkedIn.